Propanc Biopharma Inc

Propanc Biopharma Inc a biopharmaceutical company focuses on the development of cancer treatments for patients with pancreatic ovarian and colorectal cancer in Australia Its lead product is PRP a formulation that is in preclinical phase of development designed to enhance the anticancer effects of multiple enzymes acting synergistically The company has a research collaboration with University of Jaen to commence the POP1 joint drug discovery program The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma Inc in April 2017 Propanc Biopharma Inc was incorporated in 2007 and is based in Camberwell Australia